Department of Medicine, Gemeinschaftskrankenhaus Bonn, Bonner Talweg 4-6, D-53113 Bonn, Germany.
BMC Gastroenterol. 2010 Jan 27;10:11. doi: 10.1186/1471-230X-10-11.
Although gastrointestinal endoscopy with sedation is increasingly performed in elderly patients, data on combined sedation with midazolam/propofol are very limited for this age group.
We retrospectively analyzed 454 endoscopic procedures in 347 hospitalized patients >or= 70 years who had received combined sedation with midazolam/propofol. 513 endoscopic procedures in 397 hospitalized patients < 70 years during the observation period served as controls. Characteristics of endoscopic procedures, co-morbidity, complications and mortality were compared.
Elderly patients had a higher level of co-morbidity and needed lower mean propofol doses for sedation. We observed no major complication and no difference in the number of minor complications. The procedure-associated mortality was 0%; the 28-day mortality was significantly higher in the elderly (2.9% vs. 1.0%).
In this study on elderly patients with high level co-morbidity, a favourable safety profile was observed for a combined sedation with midazolam/propofol with a higher sensitivity to propofol in the elderly.
尽管镇静状态下的胃肠内镜检查在老年患者中越来越常见,但针对该年龄组的咪达唑仑/丙泊酚联合镇静的数据非常有限。
我们回顾性分析了 347 名 >70 岁住院患者的 454 例内镜检查,这些患者接受了咪达唑仑/丙泊酚联合镇静。在观察期间,397 名 <70 岁的住院患者进行了 513 例内镜检查作为对照。比较了内镜检查的特征、合并症、并发症和死亡率。
老年患者合并症的严重程度更高,需要的丙泊酚镇静剂量更低。我们没有观察到严重并发症,也没有观察到轻微并发症的数量存在差异。与操作相关的死亡率为 0%;28 天死亡率在老年组显著升高(2.9% vs. 1.0%)。
在这项针对合并症严重程度高的老年患者的研究中,咪达唑仑/丙泊酚联合镇静具有良好的安全性,老年患者对丙泊酚的敏感性更高。